Are Zepbound and Wegovy the same?

Introduction

Two breakthrough weight loss medications, Zepbound and Wegovy, have recently gained FDA approval. Zepbound, developed by Eli Lilly, operates as a GLP-1 receptor agonist, activating GIP and GLP-1 hormone receptors. Wegovy, produced by Novo Nordisk, mimics hormones that regulate appetite by interacting with GLP-1 receptors. Both drugs have shown promising outcomes in aiding weight loss, with Zepbound resulting in over a 20% average weight reduction on higher doses, and Wegovy facilitating a remarkable 15% to 25% body weight loss. However, accessibility remains a concern due to the high cost of these medications, with Wegovy priced at $1,300 per month and Zepbound at $1,000. Unfortunately, these steep costs have confined their usage to the affluent, as private insurers often either do not cover the medications or impose stringent access restrictions.

Breaking Down the Differences Between Zepbound and Wegovy

Is Zepbound the New Wegovy, or Just a Copycat?

Zepbound and Wegovy are two medications designed to aid weight loss when paired with exercise and a calorie-deficient diet. While they share this common goal, they differ in their active ingredients — Zepbound utilizes tirzepatide, while Wegovy relies… Continue reading